The activation of PPARs attenuates the development of NAFLD through its regulation of the lipid metabolism and reducing IR (PPAR-α, PPAR-γ) or through the attenuation of liver inflammation (PPAR-β/δ) (64). This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.